Assignee
ANGEX PHARMACEUTICAL INC
US·3 granted patents·2 pending applications·0 citations·filing 2018–2021
Top patents by PatentIndex Score
5 records- 0152US2022089612A1Heterocyclic compounds as prmt5 inhibitorsANGEX PHARMACEUTICAL INC·Filed 2021·Application pending·0 cites
- 0247US11180497B2Cyclic compounds as immunomodulating agentsANGEX PHARMACEUTICAL INC·Filed 2018·Granted Nov 23, 2021·0 cites·25 claims
- 0343US11098046B2Macrocyclic compounds as TRK kinase inhibitors and uses thereofANGEX PHARMACEUTICAL INC·Filed 2018·Granted Aug 24, 2021·0 cites·21 claims
- 0440US11358949B2Carbamate and urea compounds as multikinase inhibitorsANGEX PHARMACEUTICAL INC·Filed 2018·Granted Jun 14, 2022·0 cites·20 claims
- 0538US2020369667A1Heterocyclic compounds as prmt5 inhibitorsANGEX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANGEX PHARMACEUTICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →